by Richard Nordstrom, May 1, 2022
Where is the money going?
Let’s take a look at some big deals in Health-tech that closed in the first quarter this year.
Artificial intelligence (AI) continues to draw significant investment for large and midsize investors. Millions of bits of data are being generated every day and hospital systems have to invest heavily into data analytics to make this massive amount of information useable. One example is Clarify Health an AI based enterprise data analytics company brought in $150 million in fresh funding to bulk up its clinical informatics capabilities and expand its value-based payments technology.
SoftBank Vision Fund 2 led the series D round and was joined by funds and accounts managed by BlackRock and Memorial Hermann Health System along with existing investors Insight Partners, Spark Capital, KKR, Aspenwood Ventures, Rivas Capital and Sigmas Group.
In addition to data analytics investments in artificial intelligence tools designed to support clinical decision-making have picked up steam in healthcare in the last few years as the algorithms grow more sophisticated and gain provider trust.
Now, fertility startup Alife Health is leveraging those advancements to lower costs and improve outcomes for in vitro fertilization treatments.
Alifie raised $22 million in series A funding, which will support the company’s goal of bringing its fertility products to market and conduct clinical studies for products still in development. The series A round was co-led by existing investor Deena Shakir at Lux Capital plus new investors Rebecca Kaden at Union Square Ventures and Anarghya Vardhana at Maveron.
The pandemic showed that technology can enable access to healthcare and the investment money soon followed. Telehealth provider Antidote Health raised $22 million in a series A funding round to power its artificial-intelligence-enabled app championing low-cost care.
Launched in January 2021, the company offers 24/7 telehealth services across the U.S. focused on quality and affordability, with individual membership plans starting at $35 a month and family plans also available.
Antidote’s app also leverages AI for aspects of care like clinical decision support as well as patient scheduling, which helps providers engage meaningfully with patients and keeps costs down, according to the company.
